High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma

Abstract Carbohydrate antigen 19‐9 (CA19‐9) fails to demonstrate the predictive value for early detection pancreatic ductal adenocarcinoma (PDAC). Glypican‐1 (GPC1+) exosomes may serve as a noninvasive diagnostic tool to detect early stages of PDAC. Therefore, it is necessary to explore the serum GP...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Cong‐ya Zhou, Yi‐ping Dong, Xiao Sun, Xin Sui, Hong Zhu, Ya‐qin Zhao, Yuan‐yuan Zhang, Clifford Mason, Qing Zhu, Su‐xia Han
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2018-11-01
Serie:	Cancer Medicine
Soggetti:	carbohydrate antigen 19‐9 diagnosis glypican‐1 pancreatic ductal adenocarcinoma prognosis serum biomarker
Accesso online:	https://doi.org/10.1002/cam4.1833
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!